Interrater reproducibility of the Myoton and durometer devices to quantify sclerotic chronic graft-versus-host disease-Reference-Cited by-同舟云学术

Interrater reproducibility of the Myoton and durometer devices to quantify sclerotic chronic graft-versus-host disease

Published:2023-05-25 Issue:9 Volume:315 Page:2545-2554
ISSN:1432-069X
Container-title:Archives of Dermatological Research
language:en
Short-container-title:Arch Dermatol Res

Author:

Ghosh Shramana,Baker Laura,Chen Fuyao,Khera Zain,Vain Arved,Zhang Kathy,Hood Alexis,Smith Hayden,Chen Heidi,Jagasia Madan,Tkaczyk Eric

Funder

U.S. Department of Veterans Affairs

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00403-023-02626-1.pdf

Reference23 articles.

1. Lee SJ, Wolff D, Kitko C et al (2015) Measuring therapeutic response in chronic graft-versus-host disease. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 response criteria working group report. Biol Blood Marrow Transplant 21:984–999. https://doi.org/10.1016/j.bbmt.2015.02.025

2. Mitchell SA, Jacobsohn D, Thormann Powers KE et al (2011) A multicenter pilot evaluation of the national institutes of health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change. Biol Blood Marrow Transplant 17:1619–1629. https://doi.org/10.1016/j.bbmt.2011.04.002

3. MyotonPRO Digital Palpation Device User Manual. Myoton Muscle Diagnostics. https://www.myoton.com/UserFiles/Updates/MyotonPRO_User_Manual.pdf. Accessed 6 Jan 2022.

4. Schneider S, Peipsi A, Stokes M et al (2015) Feasibility of monitoring muscle health in microgravity environments using Myoton technology. Med Biol Eng Comput 53:57–66. https://doi.org/10.1007/s11517-014-1211-5

5. Merkel PA, Silliman NP, Denton CP et al (2008) Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial. Arthritis Rheum 59:699–705. https://doi.org/10.1002/art.23564

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mTG-Gelatin phantoms as standardized testbeds for skin biomechanical measurements with Myoton;Journal of the Mechanical Behavior of Biomedical Materials;2024-10

2. Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation;Blood Advances;2024-08-30

3. Reliability of MyotonPro in measuring the biomechanical properties of the quadriceps femoris muscle in people with different levels and types of motor preparation;Frontiers in Sports and Active Living;2024-08-29

4. Performance of myotonometer in the assessment of skin involvement in systemic sclerosis;Clinical Rheumatology;2023-12-20